×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


20265 views


The treatment of Peripheral Artery Disease (PAD) has known an important evolution in the last years. An important limitation of current endovascular therapy remains the occurrence of restenosis. In order to minimize restenosis rates, Drug-Eluting Technologies (DET) are evolving. The use of drug-eluting stents (DES) in coronary arteries shows beneficial results, leading to investigation of DES in PAD.

In this web symposium, we give an overview of current available data on PAD treatment with drug eluting technologies.
Through video cases performed by expert operators, discover techniques and devices to improve the use of DET in your daily practice. 

Program

  • Debate with our experts : How Drug Eluting Technologies will revolutionize your practice?
  • 1st case : Calcified left SFA - Double access ( Antegrade + Retrograde)

  • How to use DET based on clinical data review in 2016? – Lecture by Dr Thomas Zeller
  • 2nd case : Polystenotic calcified right SFA Antegrade approach - DES and DEB combination therapy

  • Eluvia, designing a revolutionary drug eluting stent for SFA interventions – Lecture by Jaydeep Kokate
  • 3rd case : Short left superficial femoral artery Eluvia stenting

  • My experience in DET : indications and algorythm - Lecture by Dr Koen Deloose

Educational objectives

  • Discuss current trends and approaches to the treatment of PAD with the use of DET, in terms of patient’s outcomes
  • Demonstrate advanced techniques and new drug eluting technologies in the treatment of peripheral artery disease
  • Provide platform for discussion and mutual learning

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists)
  • Referring physicians of patients with peripheral artery disease
Shooting date : 2016-07-13
Last update : 2021-06-09
Max Amor
Essey-lès-Nancy, France
Koen Deloose
Dendermonde, Belgium
Thomas Zeller
Bad Krozingen, Germany

Suggestions

May 2017
Honolulu : Monday, May 8th 2017 from 11:30pm to 01am (GMT+2)
San Francisco : Tuesday, May 9th 2017 from 02:30am to 04am (GMT+2)
New York : Tuesday, May 9th 2017 from 05:30am to 07am (GMT+2)
Buenos Aires : Tuesday, May 9th 2017 from 06:30am to 08am (GMT+2)
Reykjavik : Tuesday, May 9th 2017 from 09:30am to 11am (GMT+2)
London / Dublin : Tuesday, May 9th 2017 from 10:30am to 12pm (GMT+2)
Paris / Berlin : Tuesday, May 9th 2017 from 11:30am to 01pm (GMT+2)
Istanbul : Tuesday, May 9th 2017 from 12:30pm to 02pm (GMT+2)
Moscou / Dubaï : Tuesday, May 9th 2017 from 01:30pm to 03pm (GMT+2)
Bangkok : Tuesday, May 9th 2017 from 04:30pm to 06pm (GMT+2)
Shanghai : Tuesday, May 9th 2017 from 05:30pm to 07pm (GMT+2)
Tokyo : Tuesday, May 9th 2017 from 06:30pm to 08pm (GMT+2)
Sydney : Tuesday, May 9th 2017 from 08:30pm to 10pm (GMT+2)
Wellington : Tuesday, May 9th 2017 from 10:30pm to 12am (GMT+2)

DCB or DES: I want choice (Live session)

Updated algorithm for your daily practice

Share

CLIC 2019: Live Case #4

Dr Shannon D. Thomas, Dr Elena Herrero & Dr Luis Mariano Palena

Share
Scroll Up